48-week viral suppression rates in people with HIV starting long-acting CAB/RPV with initial viremia.
Hickey MD, Gistand N, Grochowski J, Mayorga-Munoz F, Imbert E, Szumowski JD, Oskarsson J, Shiels M, Dilworth S, Appa A, Havlir DV, Gandhi M, Christopoulos K.
Hickey MD, et al. Among authors: christopoulos k.
Clin Infect Dis. 2024 Oct 5:ciae500. doi: 10.1093/cid/ciae500. Online ahead of print.
Clin Infect Dis. 2024.
PMID: 39367871